Can-Fite BioPharma Ltd. (TLV:CANF)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.900
0.00 (0.00%)
Apr 1, 2025, 4:45 PM IDT

Can-Fite BioPharma Revenue

Can-Fite BioPharma had revenue of $158.00K USD in the quarter ending June 30, 2024, a decrease of -19.39%. This brings the company's revenue in the last twelve months to $667.00K, down -15.89% year-over-year. In the year 2023, Can-Fite BioPharma had annual revenue of $743.00K, down -8.27%.

Revenue (ttm)
$667.00K
Revenue Growth
-15.89%
P/S Ratio
12.02
Revenue / Employee
$83.38K
Employees
8
Market Cap
59.01M ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023743.00K-67.00K-8.27%
Dec 31, 2022810.00K-43.00K-5.04%
Dec 31, 2021853.00K90.00K11.80%
Dec 31, 2020763.00K-1.27M-62.45%
Dec 31, 20192.03M-1.79M-46.81%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical Industries 60.26B
Danel (Adir Yeoshua) 2.77B
Kamada 586.24M
Bait Bakfar 103.40M
Novolog (Pharm-Up 1966) 2.02B
Ilex Medical 982.96M
BrainsWay 149.39M
SofWave Medical 217.27M
Revenue Rankings